镰状细胞病基因治疗后发生急性髓系白血病一例
本文报告一名女性镰状细胞病患者在接受LentiGlobin(bb1111,lovotibeglogene autotemcel)基因治疗后约5.5年发生急性髓系白血病,该患者属于HGB-206研究初始队列(A组)。分析显示 blast 细胞携带BB305慢病毒载体插入位点,但因果调查认为白血病与载体插入无关,因插入位点位置、blast 细胞中转基因表达极低且对周围基因表达无影响;诊断后存在多个易感急性髓系白血病的体细胞突变,提示镰状细胞病患者移植后血液系统恶性肿瘤风险增加。
要点
- 镰状细胞病患者接受LentiGlobin基因治疗后约5.5年发生急性髓系白血病(HGB-206研究A组)。
- blast 细胞含BB305慢病毒载体插入位点,但因果调查认为白血病与载体插入无关。
- 诊断后存在多个易感急性髓系白血病的体细胞突变,提示移植后血液系统恶性肿瘤风险增加。
核心结论
- 因果调查认为该急性髓系白血病与BB305慢病毒载体插入无关。
- 镰状细胞病患者移植后血液系统恶性肿瘤风险可能增加,可能与基础疾病、移植操作及治疗后疾病控制不佳相关。
研究设计与样本
- 病例报告:一名女性镰状细胞病患者在HGB-206研究初始队列(A组)接受LentiGlobin(bb1111,lovotibeglogene autotemcel)基因治疗后约5.5年发生急性髓系白血病。
主要发现
- 外周血样本分析显示 blast 细胞含有BB305慢病毒载体插入位点。
- 因果调查基于插入位点位置、blast 细胞中转基因表达极低及对周围基因表达无影响,认为白血病与载体插入无关。
- 诊断后检出多个易感急性髓系白血病的体细胞突变。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Gene therapy with LentiGlobin for sickle cell disease (bb1111, lovotibeglogene autotemcel) consists of autologous transplantation of a patient's hematopoietic stem cells transduced with the BB305 lentiviral vector that encodes the βA-T87Q-globin gene. Acute myeloid leukemia developed in a woman approximately 5.5 years after she had received LentiGlobin for sickle cell disease as part of the initial cohort (Group A) of the HGB-206 study. An analysis of peripheral-blood samples revealed that blast cells contained a BB305 lentiviral vector insertion site. The results of an investigation of causality indicated that the leukemia was unlikely to be related to vector insertion, given the location of the insertion site, the very low transgene expression in blast cells, and the lack of an effect on expression of surrounding genes. Several somatic mutations predisposing to acute myeloid leukemia were present after diagnosis, which suggests that patients with sickle cell disease are at increased risk for hematologic malignant conditions after transplantation, most likely because of a combination of risks associated with underlying sickle cell disease, transplantation procedure, and inadequate disease control after treatment. (Funded by Bluebird Bio.).
引用
- Goyal S, Tisdale J, Schmidt M, et al. Acute Myeloid Leukemia Case after Gene Therapy for Sickle Cell Disease. N Engl J Med. 2021. PMID: 34898140. doi:10.1056/NEJMoa2109167
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。